Leptin deficiency is treated with the recombinant human leptin analog metreleptin, while individuals with LEPR, PCSK1, or POMC deficiencies can now be treated with the MC4R agonist setmelanotide. The gene discussed is POMC; the disease is hyperinsulinemic hypoglycemia, familial, 4.